BioProcess Insider Interviews

[Available On-Demand]
Search General Info
One on One Interviews - Felix Hsu, SVP & Global Head, Wuxi Advanced

Abstract: Innovation and platform technologies will drive cell and gene success, says WuXi Advanced Therapies

Felix Hsu, Chief Commercial and Chief Business Officer, spoke with Bioprocess Insider editor Dan Stanton to talk about the technical struggles in developing and manufacturing advanced therapies and how the current emergence of process technologies available to support speed-to-market will evolve into fewer, more efficient platform as the sector matures.